10:45-11:20

Pharmaceutical Approaches to Antiviral Drug Development

Amy Patick, Ph.D. and Peter Dragovich, Ph.D., Pfizer Inc.

11:20-11:30

Discussion

11:30

BREAK

11:45-12:10

Vaccines: Can We Prevent the Unexpected?

Alan Shaw, Ph.D., Merck Research Laboratories

12:10-12:30

Discussion

12:30-12:50

SARS: Clearing the Air

Jerome Schentag, Pharm.D., State University of New York-Buffalo

12:50-1:00

Discussion

1:00

LUNCH

Session VI: Panel Discussion—Preparing for the Next Disease Outbreak

Moderator: Frederick Sparling, M.D., Professor of Medicine, Microbiology, and Immunology, University of North Carolina

2:00

Discussants:

The Quest to Define and Control SARS: Robert Breiman, M.D., Centre for Health and Population Research, Dhaka, Bangladesh

Regulatory Laboratory Planning/Preparedness: Kathryn Carbone, M.D., Center for Biologics, Food and Drug Administration

Future Threats Assessment: Karen Monaghan, NIC, National Intelligence Council Report

Public Health Law: Gene Matthews, J.D., Legal Advisor to CDC

Modeling a Response Strategy: Nathaniel Hupert, M.D., M.P.H., Weill Cornell Medical College

Face to Face w/Influenza: Robert Webster, Ph.D., St. Jude Children’s Research Hospital

3:30

Open Discussion

5:00

Closing Remarks/Adjourn



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement